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Melamine, a widely used chemical found in many products in
daily use, became a public health concern due to melamine-
associated urinary stone formation in children. In adults, it is
still unknown whether low-dose melamine exposure may
also cause urolithiasis. To address this question, we studied
211 Taiwanese patients diagnosed with calcium urolithiasis
and 211 age- and gender-matched controls. All patients
completed a detailed questionnaire and provided blood and
urine samples for biochemical analysis. Urinary melamine
concentrations were measured by triple-quadrupole liquid
chromatography tandem mass spectrometry. Compared
with those whose urinary melamine levels were below
the detection limit of the method, patients with urinary
melamine levels of up to 3.11ng/ml and those with levels
of X3.12ng/ml had 3.01- and 7.64-fold increased risk,
respectively, of calcium urolithiasis after adjusting for
educational level, fluid intake, cigarette smoking, betel
quid chewing, alcohol drinking, urinary uric acid, calcium,
creatinine, and estimated creatinine clearance rate. The
population attributable risk of calcium urolithiasis averaged
50% when melamine was detected in the urine, after
considering other covariates. MALDI-TOF mass spectrometry
detected melamine in the stones of nine representative
patients who had measurable urinary melamine levels.
Thus, low-dose melamine exposure can play an important
role in calcium urolithiasis in Taiwanese adults.
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Melamine, a widely used chemical found in many daily use
products, emerged as a public health concern in 2007 due to
an investigation of melamine contamination of pet food
resulting in many deaths of animals in the United States and
elsewhere.1,2 Subsequently, an outbreak of childhood urinary
stones caused by melamine-tainted formula was first reported
in China in September 2008. More than 294,000 children
were affected, over 50,000 were hospitalized, and at least
6 died.3 Since then, melamine has been detected in many
foodstuffs around the globe, and melamine food conta-
mination is considered to be more pervasive than originally
thought.3–5
Adult urolithiasis is a multifactorial disease influenced
by environmental, hormonal, and genetic factors.6 It is a
global problem that affects B10% of the populations in
every region, culture, and race.7 During recent decades, the
prevalence and incidence of adult urolithiasis have steadily
increased worldwide. In addition, its recurrence rate is very
high; once diagnosed, 50% of adult urolithiasis patients
recurred in 5–10 years and 75% in 20 years.7 Thus, loss of
quality of life and productivity and increase of economic
burden on medical expenses are expected to be large.7
Until now, melamine-associated urinary stones were
only reported in children.8 Despite the main contents of
urolithiasis were reported to be uric acid and melamine in
children,9 one animal study has reported that calcium uro-
lithiasis also contained a mixture of melamine and calcium
oxalate crystals,10 suggesting that melamine might affect
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different kinds of stone formation. However, in adults, it is
still unknown whether a low dose of melamine exposure may
also cause urolithiasis. To address this question, we did a
preliminary study and found that higher urinary melamine
concentration was associated with an increased risk of
developing both uric acid and calcium urolithiasis in adults,
even though the sample size was small (11 uric acid and
21 calcium urolithiasis patients).11 As calcium urolithiasis is
the most common type of adult urolithiasis,12 we conducted
a large-scale case–control study to further examine the
relationship of urinary melamine concentration with calcium
urolithiasis risk in Taiwanese population.
RESULTS
Case patients had significantly higher body mass index, drank
less fluid per day, and had a higher prevalence of current
smoking, betel quid chewing, and alcohol drinking than
the controls (Table 1). In laboratory data, case patients had
significantly higher estimated creatinine clearance rate
(eCCr) and higher urinary excretion of calcium and uric
acid, but significantly lower serum calcium and urinary creati-
nine, than controls (Table 1). Urinary melamine levels ranged
fromo method of detection limit (MDL) to 192.32 ng/ml in
case patients and from o MDL to 55.56 ng/ml in controls.
The number (%) of detectable melamine levels in case
patients (n¼ 131, 62.1%) was significantly higher than that in
controls (n¼ 43, 20.4%; McNemar test¼ 11.13, Po0.0001;
Table 2). The results remained the same, even when stratified
by gender, estimated glomerular filtration rate (eGFR), and
stone episodes (data not shown).
Table 2 shows the similar positive association between
urinary melamine levels and the risk of calcium urolithiasis
when we considered different indicators of renal function
(eGFR in model 1 and eCCr in model 2). Compared with
those whose urinary melamine levels were below MDL,
subjects with urinary melamine levels of MDL-3.11 and
X3.12 ng/ml had 3.01- and 7.64-fold risks, respectively,
of calcium urolithiasis after adjusting for educational level,
Table 1 | Demographic and clinical characteristics among calcium urolithiasis patients and controls
Variables Controls (N=211) N (%) Calcium urolithiasis (N=211) N (%) P-valuea
Gender
Male 132 (62.6) 132 (62.6)
Female 79 (37.4) 79 (37.4)
Years of education
p9 91 (43.1) 114 (54.0) 0.029
49 120 (56.9) 97 (46.0)
Fluid intake (l/day)
42 58 (27.5) 26 (12.3) o0.001
1–2 113 (53.6) 110 (52.1)
o1 40 (19.0) 75 (35.6)
Personal habits
Current smokers 46 (21.8) 73 (34.6) 0.002
Current betel quid chewers 12 (5.7) 33 (15.6) 0.002
Current drinkers 29 (13.7) 45 (21.3) 0.024
Mean±s.d. (median, IQR)
Age (years) 52.4±11.9 (52.0, 45.0–59.0) 52.3±12.0 (53.0, 44.0–59.0) 0.425
BMI (kg/m2) 24.1±4.0 (23.9, 22.0–25.7) 25.3±3.6 (25.0, 22.9–27.3) 0.002
Laboratory data
eGFR 66.1±13.9 (64.7, 58.8–74.6) 68.1±18.5 (66.3, 56.1–79.2) 0.161
eCCr 65.8±18.9 (66.6, 54.7–77.4) 71.9±26.0 (66.6, 56.5–83.1) 0.001
eGFR o60ml/min per 1.73m2, N (%) 58 (27.5) 69 (32.7) 0.194
Serum, mg/dl
Uric acid 6.78±1.53 (6.65, 5.80–7.70) 7.06±2.09 (7.00, 5.80–8.07) 0.070
Calcium 8.78±0.52 (8.70, 8.40–9.10) 8.59±0.88 (8.70, 8.20–9.10) 0.016
Phosphate 3.91±0.38 (4.00, 3.70–4.20) 3.93±1.60 (3.59, 2.95–4.47) 0.821
Creatinine 1.20±0.57 (1.10, 1.00–1.30) 1.18±0.52 (1.13, 0.92–1.29) 0.703
Urine, g/g Cr
Uric acid 0.20±0.18 (0.14, 0.08–0.26) 0.50±0.19 (0.48, 0.38–0.60) o0.0001
Calcium 0.09±0.06 (0.07, 0.05–0.12) 0.14±0.11 (0.11, 0.07–0.18) o0.0001
Phosphate 0.44±0.18 (0.41, 0.33–0.53) 0.46±0.20 (0.44, 0.32–0.58) 0.142
Urine creatinine, mg/dl 168.97±85.31 (164.70, 104.70–227.63) 75.68±49.66 (68.70, 36.40–105.60) o0.0001
Abbreviations: BMI, body mass index; Cr, creatinine; eCCr, estimated creatinine clearance rate calculated by the Modification of the Cockcroft-Gault Calculator (adjusted by
age, gender, serum creatinine, and weight), unit as ml/min; eGFR, estimated glomerular filtration rate calculated by the Modification of Diet in Renal Disease (MDRD)
calculator-extended version (adjusted by age, gender, serum creatinine, and race), unit as ml/min per 1.73m2; IQR, interquartile range.
aP-values were calculated using univariate conditional logistic regression for category variables and paired t-test for continuous variables.
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fluid intake, cigarette smoking, betel quid chewing, alcohol
drinking, urinary uric acid, urinary calcium, urinary
creatinine, and eCCr (Trend test, P¼ 0.002; model 2 in
Table 2).
The population attributable risk percentage for calcium
urolithiasis ranged 47.9–52.9% in urinary melamine, after
considering for urinary uric acid (80.9–82.0%), fluid intake
(30.7–60.1%), and other covariates (Table 3). When com-
bined with these three factors, it accounted for B96.0% of
attributable risks of calcium urolithiasis.
To detect whether stones contained melamine, we
randomly selected 9 from 41 stone patients who had detectable
urinary melamine level (4MDL) and whose stored stones
were still available and analyzed their stones using matrix-
assisted laser desorption/ionization time-of-flight mass
spectrometry (Autoflex III, Bruker Daltonics GmbH, Leipzig,
Germany).13 We found that melamine content could be
detected in 9 out of 9 (100%) stones (Figure 1).
DISCUSSION
To our knowledge, only one study has reported that calcium
urolithiasis in animals contained a mixture of melamine and
calcium oxalate crystals,10 but no human study is available.
Melamine remains in its original form after metabolism and
90% of the administered dose was excreted in urine within
24 h in rats;14 therefore, measuring melamine in urine can be
directly linked to the toxic exposure effects. After the
outbreak of melamine-tainted formula, only four studies
had measured melamine concentration in urine,11,15–17 and
two (one in children16 and the other in adults11 from us) of
them found the link between urinary melamine levels and
urolithiasis risk. The findings of this study add additional
evidence that melamine exposure measured by urinary
melamine level is associated with calcium urolithiasis in
human adults.
Until now, it was not clear how much melamine is safe for
human intake, and whether long-term low level of melamine
intake may confer a health risk to humans.5 Recently, the
World Health Organization (WHO) and the US Food and
Drug Administration (FDA) lowered the melamine level of
their recommended tolerable daily intake.18 Subsequently,
Chen et al.19 reported that several children with melamine-
associated renal stones had an intake below the updated
WHO- or FDA-recommended tolerable daily intake. In
addition, Li et al.20 found that children exposed to melamine
levels even below 0.2mg/kg per day (WHO-recommended
Table 2 | The relationship of urinary melamine concentration with the risk of calcium urolithiasis in logistic regression models
Urinary melamine concentration
(ng/ml), N (%)
Controls
(N=211)
Calcium urolithiasis
(N=211)
OR
(95% CI)
Model 1 AOR1
(95% CI)a,c
Model 2 AOR2
(95% CI)b,c
MDL 168 (79.6) 80 (37.9) 1 1 1
MDL-3.11 23 (10.9) 64 (30.3) 5.54 (2.98–10.31) 3.46 (0.84–14.23) 3.01 (0.76–11.89)
X3.12 20 (9.5) 67 (31.8) 6.95 (3.60–13.42)d 8.33 (1.93–35.91)d 7.64 (1.98–29.51)d
Abbreviations: AOR, adjusted odds ratio; CI, confidence interval; MDL, method detection limit; OR, odds ratio.
aModel 1, adjusting for educational level, fluid intake, cigarette smoking, betel quid chewing, alcohol drinking, urinary uric acid, urinary calcium, urinary creatinine, body mass
index (BMI), and estimated glomerular filtration rate (eGFR).
bModel 2, adjusting for educational level, fluid intake, cigarette smoking, betel quid chewing, alcohol drinking, urinary uric acid, urinary calcium, urinary creatinine, and
estimated creatinine clearance rate (eCCr).
cUric acid, calcium, and creatinine in urine were log-transformed.
dTrend test from MDL, MDL-3.11, and X3.12 ng/ml in urinary melamine: Po0.0001 in crude OR; P=0.003 in AOR1; and P=0.002 in AOR2.
Table 3 | The population attributable risk proportions (PAR%) of calcium urolithiasis with urinary melamine, urinary uric acid,
and fluid intake
Urinary melamine (ng/ml) Adjusted PAR% 0a Adjusted PAR% 1b,d Adjusted PAR% 2c,d
Median detectable level of urinary melamine (ng/ml) 52.9% 51.6% 47.9%
MDL-3.11 24.8% 22.2% 18.9%
X3.1 2 28.1% 29.4% 29.0%
Urinary uric acid 82.0% 80.9% 80.9%
Fluid intake 30.7% 48.1% 60.1%
PAR for two combined factors
Urinary uric acid + fluid intake 87.3% 89.6% 91.6%
Urinary uric acid + melamine 93.0% 92.5% 91.9%
Fluid intake + melamine 67.2% 74.5% 78.8%
PAR for those three above factors 94.8% 95.5% 96.0%
Abbreviation: MDL, method detection limit.
aModel 0, adjusting for fluid intake, urinary uric acid, and urinary melamine.
bModel 1, adjusting for educational level, fluid intake, cigarette smoking, betel quid chewing, alcohol drinking, urinary uric acid, urinary calcium, urinary creatinine, body mass
index (BMI), estimated glomerular filtration rate (eGFR), and urinary melamine.
cModel 2, adjusting for educational level, fluid intake, cigarette smoking, betel quid chewing, alcohol drinking, urinary uric acid, urinary calcium, urinary creatinine, estimated
creatinine clearance rate (eCCr), and urinary melamine.
dCalcium and creatinine in urine were log-transformed.
748 Kidney International (2011) 80, 746–752
or ig ina l a r t i c l e C-C Liu et al.: Melamine and calcium urolithiasis
tolerable daily intake) still have a 1.7 times higher risk
of developing urolithiasis than those without mela-
mine exposure in 683 renal stone children and 6498 children
controls. Hsieh et al.18 further reported that a lower tolerable
daily intake of melamine to 0.0081mg/kg bw/day should be
considered in humans. All these studies18–20 and ours support
that even low level of melamine exposure may be a risk factor
for urolithiasis formation.
High-dose exposure to melamine from melamine-tainted
food consumption may directly interact with cyanuric acid to
form crystals and result in kidney toxicity in animals21 and
young children.22 However, there were limited data on the
mechanisms of low-dose melamine exposure.11 We pre-
viously proposed two possible mechanisms that may explain
why long-term low level of melamine exposure could induce
calcium urolithiasis formation, including renal tubular
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Figure 1 |One representative spectrum of melamine content in the stone specimen from one calcium stone patient with urinary
melamine level of 1.58 ng/ml by the technique of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF MS and MS/MS). (a) Standard of one melamine cyanurate synthetic stone showing melamine signal of (MþH)þ at m/z 127
by MALDI mass spectra (upper); one real stone specimen (middle); the blank in MALDI matrix 2,5-dihydroxybenzoic acid (DHB) solution
(lower). (b) MALDI tandem mass spectra of the ions at m/z 127 to 85 in standard of melamine cyanurate synthetic stone (upper) and real
stone specimen (lower).
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injury, after chronic exposure to low-dose melamine and
melamine may serve as a nidus to promote stone formation
in early stages.11 In this study, we found melamine can be
detectable in stones by matrix-assisted laser desorption/
ionization time-of-flight mass spectrometry, partly support-
ing our speculations.
In addition to purposeful adulteration of melamine into
our foodstuffs, many other sources of melamine food
contamination, including chicken eggs and fish imported
from China and vegetable crops fertilized by insecticide such
as cyromazine, exist.3–5,23 Melamine is also commonly used
to manufacture a variety of tableware and was found to leach
out when it contacted with hot foods or acid.24–26 Any one or
a combination of these sources might contribute to melamine
intake in our study population and pose a risk of urolithiasis
formation in adults.
Our study has strengths and limitations. First, this is a
large-scale case–control study to illustrate the association
between urinary melamine concentration and calcium
urolithiasis in adults. Second, we used objective measurement
of urinary melamine concentration in the study subjects.
Although we measured melamine concentration in one-spot
overnight urine sample instead of 24-h urine samples, the
good correlation was noted between these two (Supplemen-
tary Figure S1 online).27 Third, the components of all stone
specimens were confirmed by infrared spectroscopy. Despite
we provide the evidence that melamine was indeed one of the
components in calcium stones themselves, several limitations
were present in this study and need to be elucidated in the
future. Potential controls were chosen from the same hospital
and we did not have the community controls who are more
representative for general population. This is a cross-sectional
design of case–control study that may not clearly elucidate
the causal effect. Finally, as we did not have information
about consumption of animal proteins and fibers and family
history of stones in questionnaire as well as oxalate and
citrate levels in urine, we were unable to control those
covariates in the conditional logistic regression models, if
they were potential confounders.
In conclusion, our findings suggest that low-dose
melamine exposure can play an important role in calcium
urolithiasis formation in adults. Other large population-
based studies are necessary to be conducted in other
geographic areas to confirm our significant findings.
MATERIALS AND METHODS
Subjects
Selection of study subjects and their characteristics were described in
detail previously.6,28 Briefly, subjects with calcium urolithiasis were
recruited from Kaohsiung Medical Center in Kaohsiung city, which
is in southwestern Taiwan, between June 2003 and February
2007.6,28 All case patients were diagnosed by ultrasonography or
radiography and proved by certified urologists (C-C Liu, S-P Huang,
Y-H Chou, W-J Wu, and C-H Huang). Their provided stone
specimens were confirmed to have calcium components by infrared
spectroscopy analysis (Spectrum RX I Fourier Transform-Infrared
System, PerkinElmer, Shelton, CT).6,12,28 No case patients were
found by X-ray to have radiolucent stones or by clinical evaluation
to have cystine or uric acid stones. Sex- and age-matched (±3 years)
controls (case/control¼ 1:1) were randomly selected from subjects
who received routine health screening at the same hospital during
the same period. The controls had no past history of urinary stone
diseases and no clinical finding of stones, as confirmed by plain
abdominal X-ray and abdominal ultrasound. Both cases and
controls lived in southern Taiwan and were excluded if they had a
history of chronic urinary tract infection, renal failure, chronic
diarrhea, gout, renal tubular acidosis, primary and secondary
hyperparathyroidism, or cancer. Bedridden subjects were also
excluded. We also excluded anyone who had regularly taken
diuretics, potassium citrate, vitamin D, or calcium supplements
more than once per week within 6 months before the diagnosis of
calcium urolithiasis or interview.
Data collection
All subjects were interviewed by trained researchers using a
structured questionnaire. In case patients, clinical information
including total number of stone episodes was also collected by
questionnaire and reviewed using their medical charts.6,28
After overnight fasting, all subjects provided a 20ml whole blood
sample and a one-spot overnight urine sample from midstream of
the first void for biochemical evaluation before any intervention for
urolithiasis. The blood and urine samples were measured for total
calcium, phosphate, uric acid, and creatinine. All urinary data were
corrected by urinary creatinine levels.6,28 The eGFR and eCCr were
also calculated to evaluate renal function.11
A total of 354 calcium urolithiasis and 354 controls enrolled in
our previous study were considered as our study population.28
Among them, 211 calcium urolithiasis and their 211 matched
controls with stored urine samples were our final study subjects.
Except for eGFR and serum creatinine levels, the rest of the clinical
characteristics and laboratory data were similar in the case
subjects of this study and those not included in this study
(Supplementary Table S1 online). This study did not include 22
calcium urolithiasis patients and 22 controls from our previous pilot
study.11 This study was approved by the institutional review board
of Kaohsiung Medical University; all subjects provided written
informed consent.
Analysis of melamine in urine
Urinary melamine was measured using isotopic liquid chromato-
graphy/tandem mass spectrometry method (API4000Q: Applied
Biosystems/MDS SCIEX, Concord, Canada). The detailed analytical
method was described earlier.11 Briefly, the elute of 1ml urine sample
collected from an Oasis MCX SPE cartridge (Waters, Malford, MA)
was dried under nitrogen gas. Then, the residues were reconstituted
in 200ml mobile phase, instead of 400ml mobile phase in the previous
pilot study, which may be more sensitive to measure melamine in
urine, and subjected into liquid chromatography/tandem mass
spectrometry for analysis.11,29 The technician who measured urinary
melamine level was blinded to the case–control status.
To avoid melamine contamination of urine specimens during
storage, we investigated whether melamine would be migrated from
the anti-frozen plastic collection tubes in the urine samples. We first
pooled urine samples from volunteers who had relatively high
(B104 ng/ml) or low (oMDL) urinary melamine concentration at
room temperature for 6 h and at both 4 and 70 1C for 1 month.
Fresh ddH2O as blank control was stored at the same condition with
urine samples. We found that all the blank samples and low urinary
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melamine concentration in different stored conditions were below
MDL. In addition, the differences in the groups with high urinary
melamine concentrations were within 15% compared with the base-
line urinary melamine concentration (Supplementary Figure S2
online). Thus, our anti-frozen plastic collection tubes could not
affect melamine levels in urine samples of study subjects in different
stored conditions.
To examine whether melamine concentration of collected one-
spot urine sample can represent for the previous 8 and 24 h urinary
excretion of total melamine (Supplementary Figure S1a online), we
collected one-spot overnight urine sample and 8 and 24 h urine
samples from 14 healthy volunteers (5 males and 9 females) and
found high correlations between melamine concentration in one-
spot overnight urine sample (mg/mmol Cr) and the previous 8 and
24 h urinary excretion of total melamine (mg) (Supplementary
Figure S1b online).
Statistical analyses
Except urinary melamine levels, other characteristics were presented
as mean±s.d. and median with interquartile range, unless other-
wise indicated. As urinary melamine levels in 80 (37.9%) case
patients and 168 (79.6%) controls were below MDL, they were
categorized based on the median level of those who had detect-
able urinary melamine concentration (MDL, MDL 3.11, and
X3.12 ng/ml). In addition, the cut-point of 90th percentile in the
control group (o3.03 vsX3.03 ng/ml) was very close to the median
detectable level (3.11 ng/ml). The significant results were also similar
based on these two cut-points, and hence the latter one was
presented.
Multiple conditional logistic regression models were applied to
investigate the association between the different categories of
urinary melamine concentration and matched case–control status
after adjusting for other covariates that were significant in simple
conditional logistic regressions, including educational level, daily
fluid intake, cigarette smoking, betel quid chewing, alcohol
drinking, urinary uric acid, calcium, and creatinine, body mass
index, and eGFR for model 1, and eCCr for model 2. Urinary uric
acid, calcium, and creatinine were log-transformed. Fluid intake,
urinary uric acid, and melamine levels were the main determinants
of calcium urolithiasis in this study, and we also calculated their
population attributable risk percentages after considering other
significant variables in the model.30
In data from our previous pilot study,11 urinary melamine level
above MDL in 22 controls was 31.8% (n¼ 7). With 211 cases and
211 controls and assuming a two-sided P-value of 0.05, this study
had 92.1% power to detect a significant 2.0-fold risk noted in the
pilot study.
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SUPPLEMENTARY MATERIAL
Table S1. Demographic and clinical characteristics among calcium
urolithiasis patients in this study (n¼ 211) compared with the original
study subjects not in this study (n¼ 143).
Figure S1. (a) The experimental scheme of collecting 24-hour urine
samples for analyzing melamine in one-spot overnight urine sample
and pooled urine samples in the previous 8 hrs and 24 hrs of Day2
(X means the one-spot overnight urine sample in Day1 was not
collected) and (b) the Spearmen correlation between melamine
concentration in one-spot overnight urine sample (mg/mmol Cr) and
pooled urine melamine concentrations (mg/mmol Cr) in the previous
8 hrs and 24 hrs as well as between melamine concentration in one-
spot overnight urine sample (mg/mmol Cr) and total melamine (mg) in
the previous 8 hrs and 24 hrs pooled urine. Text summary: We
collected one-spot overnight urine sample and total urine in the
previous 8 hrs and 24 hrs to examine the correlation between
melamine levels in one-spot urine sample (mg/mmol Cr) and
excretion of total melamine in the previous 8 hrs and 24 hrs (mg)
from 14 healthy volunteers.
Figure S2. Stability of urinary melamine levels (ng/ml) in the groups
with high urinary melamine concentrations by storage in 2 ml plastic
tubes in different conditions. Values represent as mean±SD (n¼ 4,
in each group). Text summary: We pooled urine samples from
volunteers who had relatively high (B104 ng/ml) and low (oMDL)
urinary melamine concentration at room temperature for six hrs and
at both 4 1C and 70 1C for one month. Melamine levels in these
urine specimens were measured by LC-MS/MS.
Supplementary material is linked to the online version of the paper at
http://www.nature.com/ki
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